Erika Hamilton, Chair, Executive Committee Breast and Breast Program Lead at Sarah Cannon Research Institute, shared a post on LinkedIn:
“Press release this morning that HER2CLIMB-05 is positive. Proud of Sarah Cannon Research Institute‘s involvement in this study and excited to present this data at SABCS25.
Maintenance strategies in 1st line HER-2 positive BCSM are so well tolerated by patients, excited to have a strategy to prolong this maintenance period.”
More posts featuring Erika Hamilton on OncoDaily.